The battle against type 2 diabetes and obesity has long challenged patients and healthcare providers alike. Traditional approaches often focus on diet, exercise, and medications that offer limited results. In recent years, incretin-based therapies like semaglutide have brought new hope. Now, a more powerful option has entered the scene: tirzepatide. This dual-action medication is show... https://biotechlabzsupply.com/